Author

Johnathan Polikoff

Institutions: Kaiser Permanente, Kaiser Permanente San Diego Medical Center, NSABP Foundation

Observed institutions: Kaiser Permanente, Kaiser Permanente San Diego Medical Center, NSABP Foundation

OpenAlex ID: A5034403178

Abstract S3-02: NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer

2015 · Jacobs A Samuel, John W Wilson, et al. · Cancer Research · 18

Abstract P3-12-01: Impact of treatment on quality of life (QOL) and menstrual history (MH) in the NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide

2015 · Patricia A Ganz, John W Wilson, et al. · Cancer Research

Works count: 2

Citation count: 18

H-index: 1

I10-index: 1